EUVIMEDEUVIMED entdecken
Crossref

miR‐4286 promotes prostate cancer progression by targeting the expression of SALL1

Zhanqi Li, Shaoxiong Zhao, Hui Wang, Binbin Zhang, Peibo Zhang iD

The Journal of Gene Medicine · 2023

DOI: 10.1002/jgm.3127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2023. Verfasst von Zhanqi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shaanxi Nuclear Industry 215 Hospital, Xianyang, China. Hauptthemen laut MEDLINE: MicroRNAs, Prostatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate cancer (PCa) is a serious health threat for humans worldwide. Recent studies have revealed that microRNAs are associated with the progression of human cancers, including PCa. However, no study has been performed aiming to investigate the role of microNA‐4286 (miR‐4286) on PCa.

Methods

A quantitative reverse transcriptase‐polymerase chain reaction was conducted to analyze the expression level of miR‐4286 in PCa cells. The connection of miR‐4286 and spalt like transcription factor 1 (SALL1) was analyzed with a bioinformatic analysis tool, a dual‐luciferase activity reporter assay and western blotting. The effects of miR‐4286 and SALL1 on PCa cell behaviors were examined in vitro .

Results

We showed miR‐4286 expression was significantly increased in PCa cells compared to a normal cell line. Knockdown of miR‐4286 could inhibit PCa cell proliferation but promote cell apoptosis by targeting SALL1.

Conclusions

The results of the present study suggest that miR‐4286 overexpression represents a tumor promoter role in PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsProstatic NeoplasmsHumansMaleCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticTranscription Factors

Stichwörter der Autor:innen

SALL1cell apoptosiscell growthmiR-4286prostate cancer

Substanzen

MicroRNAsMIRN-4286 microRNA, humanSALL1 protein, humanTranscription Factors

Autor:innen und Institutionen

  • Department of Urology, Shaanxi Nuclear Industry 215 Hospital, Xianyang, China.
  • Department of Urology, Affiliated hospital of Yan'an university, Yan'an, China.

ORCID-Profile: Peibo Zhang

Zitieren

APA

Li, Z., Zhao, S., Wang, H., Zhang, B., & Zhang, P. (2023). miR‐4286 promotes prostate cancer progression by targeting the expression of SALL1. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3127

Vancouver

Li Z, Zhao S, Wang H, Zhang B, Zhang P. miR‐4286 promotes prostate cancer progression by targeting the expression of SALL1. The Journal of Gene Medicine. 2023. doi:10.1002/jgm.3127

BibTeX
@article{Li2023,
  author = {Li, Zhanqi and Zhao, Shaoxiong and Wang, Hui and Zhang, Binbin and Zhang, Peibo},
  title = {miR‐4286 promotes prostate cancer progression by targeting the expression of SALL1},
  journal = {The Journal of Gene Medicine},
  year = {2023},
  doi = {10.1002/jgm.3127}
}
Kostenlos starten →